Maarga Mind Care has launched an Integrated Maternal Mental Health Programme along with Maarga Divasa, an integrated day care programme aimed at supporting mothers through the emotional and psychological challenges that often come with pregnan...
Lupin Limited and Natco Pharma have received US FDA approval for Eribulin Mesylate Injection, expanding their oncology portfolio and strengthening access to generic cancer treatments in the United States market.
Delhi High Court asks CDSCO to review Zydus semaglutide approval, raising concerns over dosing safety and drug delivery design, with wider implications for India’s fast-growing GLP-1 and diabetes drug market.
How to avoid GLP-1 Side Effects. This guide offers practical, evidence-based advice. We look at the latest clinical insights. We break down simple lifestyle tweaks. These tips will help you minimize stomach issues safely.
.jpeg)
Understanding prostate cancer in India, including rising cases, symptoms, risk factors, treatment options, cost, and how innovation and healthcare advancements are shaping outcomes.
FDA inspection flags data integrity and manufacturing lapses at Dabur plant, raising compliance risks, export concerns, and quality scrutiny in the US market.
The article explores GLP-1 pathways, berberine, and Metaberine in metabolic health, highlighting multi-pathway, science-backed solutions for better glycemic control and long-term metabolic balance.
.jpeg)
Bengaluru Ebola scare ends negative, but triggers health alert as authorities ramp up airport screening, surveillance, and isolation protocols amid global outbreak concerns.
India’s heatwave crisis is turning into a public health emergency, with rising heatstroke deaths, underreported mortality, and growing strain on healthcare systems.
.jpeg)
Patent exclusivity expiry of $200–300B drugs is reshaping India’s pharma logistics. Rising generics, biosimilars, and cold-chain demand are driving investments in air cargo, ports, and compliant supply chains.
.jpg)
, CDSCO.jpg)
